Oxford BioMedica (LSE: OXB) has agreed to acquire Oxxon Therapeutics Ltd., a UK-based therapeutic vaccine company, for Gbp16 million. Oxxon has raised over $30 million in VC funding since 200a, from firms like NeoMed Management, ISIS Capital, MVM Life Science Partners, NIF and Quester Capital Management.
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.